Skip to main content
Clinical Trials/NCT02349269
NCT02349269
Completed
Not Applicable

Postoperative Atrial Fibrillation After Cardiac Surgery is Not an Independent Risk Factor for Long-term Cardiovascular Morbidity and Mortality in Anticoagulated Patients

Kuopio University Hospital0 sites519 target enrollmentJanuary 2012

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Death
Sponsor
Kuopio University Hospital
Enrollment
519
Primary Endpoint
myocardial infarction
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

The aim of the investigators trial was to evaluate association between new onset postoperative atrial fibrillation (POAF) and late cardiovascular morbidity and mortality.

Detailed Description

The material of this retrospective study consist patients without preoperative history of atrial fibrillation, participated in three different randomized controlled trials previously . A total of 519 consecutive patients underwent coronary artery bypass surgery, aortic valve replacement or combined aortic valve with coronary bypass surgery in Kuopio University Hospital from 2004 to 2008. Patients with previous episodes of atrial fibrillation (AF) or flutter and also patients with mitral valve surgery were excluded. All patients had continuous postoperative ECG monitoring for at least 48 hours. AF episodes lasting longer than 5 minutes were registered. Thereafter 12 lead ECG was recorded daily and in case of symptoms of rhythm disturbances. Medical records were reviewed during 2012 using standardized data collection protocol. Statistics Finland database was used for mortality data.

Registry
clinicaltrials.gov
Start Date
January 2012
End Date
September 2014
Last Updated
11 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Kuopio University Hospital
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • previously cardiac operation, CABG or AVR

Exclusion Criteria

  • Previous Atrial fibrillation

Outcomes

Primary Outcomes

myocardial infarction

Time Frame: 1-105 month

stroke

Time Frame: 1-105 month

cardiovascular and all-cause death

Time Frame: 1-105 month

late atrial fibrillation

Time Frame: 1-105 month

Similar Trials